サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786759

体外転写テンプレートの世界市場

In-Vitro Transcription Templates

出版日
ページ情報
英文 242 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
体外転写テンプレートの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 242 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外転写テンプレートの世界市場は2030年までに10億米ドルに達する見込み

2024年に3億5,850万米ドルと推定される体外転写テンプレートの世界市場は、分析期間2024-2030年にCAGR 18.9%で成長し、2030年には10億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるDNAテンプレートは、CAGR17.3％を記録し、分析期間終了時には3億9,530万米ドルに達すると予測されます。RNAテンプレート分野の成長率は、分析期間中CAGR17.5％と推定されます。

米国市場は9,420万米ドルと推定、中国はCAGR17.9%で成長予測

米国の体外転写テンプレート市場は2024年に9,420万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億5,620万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは17.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ17.1％と16.5％と予測されています。欧州では、ドイツがCAGR約14.0％で成長すると予測されています。

体外転写テンプレート- 主要動向と市場促進要因のまとめ

体外転写（IVT）テンプレートは、分子生物学、バイオテクノロジー、バイオ医薬品の研究において不可欠なツールとなっており、さまざまな用途でRNA合成の基盤となっています。一般的にDNAプラスミドや直鎖DNA断片に由来するこれらのテンプレートは、mRNA治療薬、ワクチン開発、遺伝子治療、CRISPRベースのゲノム編集のための合成RNAの製造を可能にします。高純度でスケーラブルなRNA合成、特にmRNAベースのワクチンや治療法の開発に対する需要の高まりが、IVTテンプレート技術の進歩を大きく後押ししています。RNAベースの医療が拡大し続ける中、最適化された効率的なIVTテンプレートの必要性は、合成生物学と治療法開発の状況を大きく変えつつあります。

技術革新はどのように体外転写テンプレートを強化しているのか？

IVTテンプレートの設計と合成における技術的進歩は、体外転写RNAの効率、安定性、収量を大幅に改善しました。最も注目すべき技術革新の一つは、転写効率を高める最適化されたプロモーター配列の開発です。T7、SP6、T3 RNAポリメラーゼ・プロモーターは、切断されたRNAや異常なRNAのような不要な副生成物を最小限に抑えながら、RNA収量を最大化するように広範囲に設計されてきました。さらに、ポリ（A）テーリング戦略や5'キャッピング技術の改良がIVTテンプレート設計に組み込まれ、治療応用のためのRNA安定性や翻訳効率を向上させています。

もう一つの重要な技術革新は、PCRベースの手法によって作製される直鎖DNAテンプレートへのシフトです。プラスミドDNAテンプレートとは異なり、直鎖DNA断片はスーパーコイル化プラスミド精製の必要性を排除し、プロセスの複雑性を軽減し、バッチ間の一貫性を向上させる。高忠実度DNAポリメラーゼと鋳型工学的戦略の使用により、IVT鋳型の品質と拡張性がさらに向上し、大規模RNA生産により適しています。さらに、CleanCap（TM）やCap1構造などの酵素的キャッピング法の統合により、合成RNAの機能的安定性が大幅に向上しており、これはmRNAベースのワクチンや治療薬にとって極めて重要です。

IVTテンプレートの進化を促す市場動向とは？

mRNAをベースとするCOVID-19ワクチンは、IVTで生成されたRNAの迅速な医薬品開発における大きな可能性を実証しました。この成功はRNAベースの医薬品パイプラインへの大きな投資に拍車をかけ、製薬会社やバイオテクノロジー企業はがん免疫療法、タンパク質代替療法、個別化ワクチン向けにIVTテンプレート能力を拡大しています。感染症ワクチン、自己免疫疾患、希少遺伝子疾患におけるmRNAベースの技術採用の増加は、IVTテンプレートの最適化における技術革新を促進しています。

もう一つの重要な動向は、CRISPRに基づく遺伝子編集への関心の高まりであり、そこではIVTテンプレートがガイドRNA（gRNA）の合成において重要な役割を果たします。CRISPR-Cas9および関連技術が進化を続けるにつれ、高純度で精密に設計されたRNA転写産物に対する需要が高まっています。このため、ゲノム編集アプリケーションにおいて高い忠実性を確保するためのテンプレート精製戦略、エラーのない合成方法、スケーラブルな生産プロセスの進歩につながっています。

さらに、合成生物学とRNAベースの診断法の拡大がIVTテンプレート市場を形成しています。研究開発はRNAセンサー、RNAアプタマー、バイオセンシング技術の製造にIVTテンプレートを活用し、次世代分子診断薬の開発を可能にしています。この動向は、特に感染症診断におけるポイントオブケア検査（POCT）や迅速核酸検出に関連しており、IVTで生成されたRNAプローブはアッセイの感度と特異性を向上させます。

IVTテンプレート市場の成長の原動力は？

体外転写用テンプレート市場の成長は、RNAベースの治療に対する需要の増加、テンプレート合成技術の進歩、バイオテクノロジーおよび分子医学における用途の拡大など、いくつかの要因によって牽引されています。主な成長要因は、mRNAベースの医薬品開発パイプラインの急速な拡大です。mRNAワクチンの成功により、幅広い疾患に対する新規RNAベース治療法の開発を目指す製薬企業や研究機関からの投資が急増し、最適化されたIVTテンプレートのニーズが高まっています。

CRISPRベースの遺伝子編集および細胞治療アプリケーションにおけるIVTテンプレートの採用が増加していることも、市場成長を後押しする大きな要因となっています。遺伝子編集技術の進歩に伴い、高品質のIVT生成ガイドRNAやテンプレート駆動型RNA分子の需要が加速しており、遺伝子治療、再生医療、精密医療におけるブレークスルーを支えています。さらに、個別化医療とRNAベースの診断への注目の高まりが、スケーラブルでカスタマイズ可能なIVTテンプレートソリューションの必要性を高めています。

製薬企業やバイオテクノロジー企業が、厳格な品質基準を維持しながらRNA製造プロセスの合理化を図る中、酵素合成や高純度RNA製造へのシフトも重要な推進力となっています。RNA治療薬に対する規制の重点が高まる中、企業は製造管理及び品質管理基準（GMP）の遵守を確実にするため、エラーのない転写システムや汚染のない酵素的アプローチなど、高度なテンプレート合成技術に投資しています。さらに、学術研究機関、バイオテクノロジー企業、開発・製造受託機関（CDMO）の連携により、IVTテンプレートの技術革新が加速しており、RNAベースの治療薬の大規模生産と商業化が可能になっています。

RNAベースの医薬品がヘルスケアに革命を起こし続ける中、高効率でスケーラブル、かつ精密に設計された体外転写テンプレートの需要は拡大し、合成生物学、遺伝子医療、バイオ医薬品開発の将来を形成すると予想されます。

セグメント

製品タイプ（DNAテンプレート、RNAテンプレート、テンプレート＆転写キット、その他の製品タイプ）;疾患（生活習慣病、遺伝性疾患、その他の疾患）;治療（ワクチン、治療）;研究ステージ（探索的、臨床）;エンドユーザー（製薬・バイオテクノロジー企業、学術・研究機関、受託研究機関）

調査対象企業の例

  • Agilent Technologies Inc.
  • Aldevron
  • Bio-Rad Laboratories Inc.
  • Bio-Synthesis Inc.
  • Cayman Chemical
  • Creative Diagnostics
  • Danaher Corporation
  • Enzo Life Sciences Inc.
  • Enzynomics Co., Ltd.
  • Eurofins Genomics LLC
  • Genaxxon BioScience GmbH
  • GeneCopoeia
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corporation
  • OriGene Technologies Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Synbio Technologies
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies
  • Vazyme Biotech Co., Ltd.
  • VectorBuilder Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP31688

Global In-Vitro Transcription Templates Market to Reach US$1.0 Billion by 2030

The global market for In-Vitro Transcription Templates estimated at US$358.5 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 18.9% over the analysis period 2024-2030. DNA templates, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$395.3 Million by the end of the analysis period. Growth in the RNA templates segment is estimated at 17.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$94.2 Million While China is Forecast to Grow at 17.9% CAGR

The In-Vitro Transcription Templates market in the U.S. is estimated at US$94.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$156.2 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.1% and 16.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.0% CAGR.

In-Vitro Transcription Templates - Key Trends & Market Drivers Summarized

In-vitro transcription (IVT) templates have become an essential tool in molecular biology, biotechnology, and biopharmaceutical research, serving as the foundation for RNA synthesis in various applications. These templates, typically derived from DNA plasmids or linear DNA fragments, enable the production of synthetic RNA for mRNA therapeutics, vaccine development, gene therapy, and CRISPR-based genome editing. The increasing demand for high-purity and scalable RNA synthesis, particularly in the development of mRNA-based vaccines and therapies, has significantly boosted advancements in IVT template technology. As RNA-based medicine continues to expand, the need for optimized and efficient IVT templates is reshaping the landscape of synthetic biology and therapeutic development.

How Are Technological Innovations Enhancing In-Vitro Transcription Templates?

Technological advancements in IVT template design and synthesis have significantly improved the efficiency, stability, and yield of in-vitro transcribed RNA. One of the most notable innovations is the development of optimized promoter sequences that enhance transcription efficiency. The T7, SP6, and T3 RNA polymerase promoters have been extensively engineered to maximize RNA yield while minimizing unwanted byproducts such as truncated or aberrant RNA species. Additionally, modifications in poly(A) tailing strategies and 5' capping technologies have been integrated into IVT template designs to improve RNA stability and translational efficiency for therapeutic applications.

Another key innovation is the shift toward linear DNA templates generated through PCR-based methods. Unlike plasmid DNA templates, linear DNA fragments eliminate the need for supercoiled plasmid purification, reducing process complexity and improving batch-to-batch consistency. The use of high-fidelity DNA polymerases and template engineering strategies has further enhanced the quality and scalability of IVT templates, making them more suitable for large-scale RNA production. Furthermore, the integration of enzymatic capping methods such as CleanCap™ and Cap1 structures has significantly improved the functional stability of synthetic RNA, which is crucial for mRNA-based vaccines and therapeutics.

What Market Trends Are Driving the Evolution of IVT Templates?

The rise of mRNA therapeutics and vaccines has been the most transformative trend in the IVT template market, with mRNA-based COVID-19 vaccines demonstrating the vast potential of IVT-generated RNA for rapid drug development. This success has spurred significant investment in RNA-based drug pipelines, with pharmaceutical companies and biotech firms expanding their IVT template capabilities for cancer immunotherapies, protein replacement therapies, and personalized vaccines. The increasing adoption of mRNA-based technologies in infectious disease vaccines, autoimmune disorders, and rare genetic conditions is driving innovation in IVT template optimization.

Another critical trend is the growing interest in CRISPR-based gene editing, where IVT templates serve as a key component in the synthesis of guide RNAs (gRNAs). As CRISPR-Cas9 and related technologies continue to evolve, the demand for highly pure and precisely engineered RNA transcripts is increasing. This has led to advancements in template purification strategies, error-free synthesis methods, and scalable production processes to ensure high fidelity in genome editing applications.

Additionally, the expansion of synthetic biology and RNA-based diagnostics is shaping the IVT template market. Researchers are leveraging IVT templates for the production of RNA sensors, RNA aptamers, and biosensing technologies, enabling the development of next-generation molecular diagnostics. This trend is particularly relevant for point-of-care testing (POCT) and rapid nucleic acid detection in infectious disease diagnostics, where IVT-generated RNA probes enhance assay sensitivity and specificity.

What Is Driving the Growth of the IVT Template Market?

The growth in the in-vitro transcription template market is driven by several factors, including the increasing demand for RNA-based therapies, advancements in template synthesis technologies, and expanding applications in biotechnology and molecular medicine. A major growth driver is the rapid expansion of mRNA-based drug development pipelines. The success of mRNA vaccines has prompted a surge in investment from pharmaceutical companies and research institutions seeking to develop novel RNA-based treatments for a wide range of diseases, thereby increasing the need for optimized IVT templates.

Another significant factor fueling market growth is the rising adoption of IVT templates in CRISPR-based gene editing and cell therapy applications. As gene-editing technologies advance, the demand for high-quality IVT-generated guide RNAs and template-driven RNA molecules is accelerating, supporting breakthroughs in gene therapy, regenerative medicine, and precision medicine. Additionally, the increasing focus on personalized medicine and RNA-based diagnostics is driving the need for scalable and customizable IVT template solutions.

The shift toward enzymatic synthesis and high-purity RNA production is also a crucial driver, as pharmaceutical and biotech companies seek to streamline RNA manufacturing processes while maintaining stringent quality standards. With the growing regulatory emphasis on RNA therapeutics, companies are investing in advanced template synthesis techniques, including error-free transcription systems and contamination-free enzymatic approaches, to ensure compliance with Good Manufacturing Practice (GMP) standards. Furthermore, the collaborations between academic research institutions, biotech firms, and contract development and manufacturing organizations (CDMOs) are accelerating IVT template innovation, enabling large-scale production and commercialization of RNA-based therapeutics.

As RNA-based medicine continues to revolutionize healthcare, the demand for highly efficient, scalable, and precisely engineered in-vitro transcription templates is expected to grow, shaping the future of synthetic biology, genetic medicine, and biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the In-Vitro Transcription Templates market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (DNA templates, RNA templates, Templates & transcription kits, Other product types); Disease (Lifestyle disease, Genetic disease, Other diseases); Treatment (Vaccine, Therapeutic); Research Stage (Exploratory, Clinical); End-Use (Pharma & Biotech Companies, Academic & Research institutes, Contract research organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Agilent Technologies Inc.
  • Aldevron
  • Bio-Rad Laboratories Inc.
  • Bio-Synthesis Inc.
  • Cayman Chemical
  • Creative Diagnostics
  • Danaher Corporation
  • Enzo Life Sciences Inc.
  • Enzynomics Co., Ltd.
  • Eurofins Genomics LLC
  • Genaxxon BioScience GmbH
  • GeneCopoeia
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corporation
  • OriGene Technologies Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Synbio Technologies
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies
  • Vazyme Biotech Co., Ltd.
  • VectorBuilder Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • In-Vitro Transcription Templates - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Expansion of mRNA Therapeutics and Vaccines Drives High-Volume Demand for IVT Templates
    • Growth in Cell and Gene Therapy R&D Strengthens Role of IVT Templates in Vector and RNA Synthesis
    • OEM Partnerships With CDMOs and Biotech Firms Spur Template Customization and Scale-Up Innovation
    • Rising Adoption of Self-Amplifying RNA and Circular RNA Boosts Need for Specialized Transcription Templates
    • Increased Investment in Personalized Cancer Vaccines Enhances Market for Custom IVT Template Production
    • Integration of IVT Templates Into Synthetic Biology Platforms Expands Application Beyond Therapeutics
    • Improved Plasmid Linearization and Template Purity Enhances Transcription Efficiency and Yield
    • Use of Enzyme-Modified and Cap-Integrated Templates Accelerates Translation Efficiency
    • Emerging Use of IVT in CRISPR Guide RNA Production Creates New Use Cases Across Research Fields
    • OEM Need for Templates With Regulatory-Grade Consistency Promotes GMP-Compliant Manufacturing
    • Increased Focus on Template Scalability Supports Transition From Bench to Clinic
    • IVT Template Supply Chain Resilience Becomes Critical Amid Global mRNA Development Booms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World In-Vitro Transcription Templates Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for In-Vitro Transcription Templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for DNA templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for DNA templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for RNA templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for RNA templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Templates & transcription kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Templates & transcription kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other product types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other product types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Exploratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Exploratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Academic & Research institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Academic & Research institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Contract research organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Contract research organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Lifestyle disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Lifestyle disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Genetic disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Genetic disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • JAPAN
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • CHINA
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • EUROPE
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 72: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for In-Vitro Transcription Templates by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • FRANCE
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 84: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • GERMANY
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • UNITED KINGDOM
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 114: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • ASIA-PACIFIC
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 144: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030

IV. COMPETITION